Proteinea
PrivateLast Round
Seed
Mar 14, 2022
Total Funding Raised
$4.75M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Proteinea operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Seed round in March 2022.
Proteinea is a biotechnology company that provides an AI-driven protein engineering platform for antibody-based therapeutic discovery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Foundation
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Proteinea Comparables
Compare Proteinea with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AI Proteins | 89% | |
| BigHat Biosciences | 84% | |
| Nabla | 84% |
For institutional investors. Book with your work email.
Proteinea Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 14, 2022 | ||||
| Accelerator | Mar 17, 2021 | ||||
| Accelerator | Feb 16, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Proteinea Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shorooq Partners | Seed |
| Flat6Labs | Accelerator |
| 500 Global | Seed |
| Sawari Ventures | Seed |
| Sadu Capital | Seed |
| VentureSouq | Seed |
| SOSV | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 1111% MoM, reaching 1.8K.
- Nov 12, 2024
Monthly visitors increased 1068% MoM, reaching 2.5K.
For institutional investors. Book with your work email.
Proteinea Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Proteinea's valuation, stock price, and market status.
Is Proteinea a public or private company?
Proteinea is a private company.
What is the current stock price of Proteinea?
Proteinea is a private company, so its shares have no public market price. Caplight tracks Proteinea's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Proteinea worth (valuation)?
Valuation information for Proteinea is not publicly available.
Can I buy Proteinea stock?
Proteinea shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Proteinea's last funding round?
Proteinea's most recent funding round was Seed on March 14, 2022.
Who are the main investors in Proteinea?
Key investors in Proteinea include Shorooq Partners, Sawari Ventures, SOSV.
Will Proteinea IPO soon?
No public IPO plans have been announced for Proteinea.
How can I track Proteinea secondary market activity?
Caplight tracks bids, offers, and trades in Proteinea's shares on secondary markets.